(Q34642403)
Statements
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes (English)
1 reference
Michelle Fanale
1 reference
Sattva Neelapu
1 reference
Larry Kwak
1 reference
Peter McLaughlin
1 reference
Jorge Romaguera
1 reference
Frederick Hagemeister
1 reference
Anas Younes
1 reference
Amanda Copeland
1 reference
Silvana de Castro Faria
1 reference
Jatin Shah
1 reference
Stefan Hart
1 reference
Jeanette Wood
1 reference
Ramesh Jayaraman
1 reference
Kantharaj Ethirajulu
1 reference
Joy Zhu
1 reference
10 September 2012
1 reference
30
1 reference
33
1 reference
4161-4167
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference